Loading...
Loading...
India's esomeprazole imports from UNITED STATES total $365.0K across 144 shipments from 15 foreign suppliers. ESPEE BIOPHARMA & FINECHEM LLC leads with $49.0K in import value; the top 5 suppliers together control 53.8% of this origin. Leading Indian buyers include DR.REDDY'S LABORATORIES LTD. This corridor reflects India's pharmaceutical import demand for esomeprazole — a diversified sourcing base with multiple active suppliers from UNITED STATES.

ESPEE BIOPHARMA & FINECHEM LLC is the leading Esomeprazole supplier from UNITED STATES to India, with import value of $49.0K across 4 shipments. The top 5 suppliers — ESPEE BIOPHARMA & FINECHEM LLC, GRANULES PHARMACEUTICALS INC, SUN PHARMACEUTICAL INDUSTRIES INC., AMSTERDAM PHARMA(APTEKA RX INC.), NILSCH LLC — collectively account for 53.8% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ESPEE BIOPHARMA & FINECHEM LLC | $49.0K | 4 | 13.4% |
| 2 | GRANULES PHARMACEUTICALS INC | $44.5K | 6 | 12.2% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES INC. | $36.8K | 7 | 10.1% |
| 4 | AMSTERDAM PHARMA(APTEKA RX INC.) | $34.3K | 10 | 9.4% |
| 5 | NILSCH LLC | $31.6K | 2 | 8.7% |
| 6 | RAFF & HALL PHARMACY | $23.9K | 17 | 6.5% |
| 7 | NEWLIFE MEDICAL(USA)INC | $16.6K | 6 | 4.5% |
| 8 | AGRACE PHARMA. | $12.6K | 6 | 3.5% |
| 9 | Espee Biopharma & Finechem LLC | $12.1K | 2 | 3.3% |
| 10 | AMSTERDAM PHARMA | $11.2K | 1 | 3.1% |
| 11 | NEW LIFE MEDICALS (USA) INC. | $10.2K | 10 | 2.8% |
| 12 | Good Health Pharma Supplies | $9.6K | 4 | 2.6% |
| 13 | ASAMAN,INC. | $8.5K | 1 | 2.3% |
| 14 | RAFF AND HALL PHARMACY | $8.5K | 1 | 2.3% |
| 15 | M/S. AMSTERDAM PHARMA(APTEKA RX INC | $5.5K | 5 | 1.5% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD | $70.8K | 24 | 19.4% |
| 2 | GRANULES INDIA LIMITED | $44.5K | 6 | 12.2% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $38.1K | 8 | 10.4% |
| 4 | AUROBINDO PHARMA LTD | $25.6K | 3 | 7.0% |
| 5 | AJANTA PHARMA LIMITED | $23.4K | 2 | 6.4% |
| 6 | MICRO LABS LIMITED | $22.3K | 10 | 6.1% |
| 7 | ALEMBIC PHARMACEUTICALS LIMITED | $21.8K | 8 | 6.0% |
| 8 | HETERO LABS LIMITED | $16.8K | 4 | 4.6% |
| 9 | MANKIND PHARMA LIMITED | $15.8K | 16 | 4.3% |
| 10 | CLIANTHA RESEARCH LIMITED | $15.4K | 3 | 4.2% |
| 11 | MYLAN LABORATORIES LIMITED | $11.8K | 4 | 3.2% |
| 12 | DR.REDDY'S LABORATORIES LIMITED | $11.4K | 1 | 3.1% |
| 13 | INTAS PHARMACEUTICALS LIMITED | $8.5K | 1 | 2.3% |
| 14 | STRIDES PHARMA SCIENCE LIMITED | $6.7K | 12 | 1.8% |
| 15 | TORRENT PHARMACEUTICALS LTD | $6.0K | 2 | 1.7% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Esomeprazole suppliers from UNITED STATES to India include ESPEE BIOPHARMA & FINECHEM LLC, GRANULES PHARMACEUTICALS INC, SUN PHARMACEUTICAL INDUSTRIES INC.. The leading supplier is ESPEE BIOPHARMA & FINECHEM LLC with import value of $49.0K USD across 4 shipments. India imported Esomeprazole worth $365.0K USD from UNITED STATES in total across 144 shipments.
India imported Esomeprazole worth $365.0K USD from UNITED STATES across 144 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Esomeprazole sourced from UNITED STATES include DR.REDDY'S LABORATORIES LTD, GRANULES INDIA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED. The largest buyer is DR.REDDY'S LABORATORIES LTD with $70.8K in imports across 24 shipments.
The total value of Esomeprazole imports from UNITED STATES to India is $365.0K USD, across 144 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
144 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists